News

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

1 year ago

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

1 year ago

Westlake Vinnolit Customers Appreciate Joint Efforts on Decarbonization

Westlake Vinnolit won the PVC category of the 2024 ‘Polymer Producer Awards’ by the Polymers for Europe Alliance (PEA), applying…

1 year ago

Neogen Announces Fourth-Quarter Earnings Release Date

LANSING, Mich., July 11, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening…

1 year ago

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare…

1 year ago

Family Dynamics Counseling Services Notice of Date Breach

MOUNT LAUREL, N.J., July 11, 2024 /PRNewswire/ -- Family Dynamics Counseling Services ("Family Dynamics") is writing to provide information regarding…

1 year ago

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

VALENCIA, Calif., July 11, 2024 /PRNewswire/ -- Valencia Technologies Corporation announced today that the Department of Health and Human Services,…

1 year ago

Koning Health Brings Advanced Breast Imaging Technology to Bedford Breast Center in Beverly Hills

BEVERLY HILLS, Calif., July 11, 2024 /PRNewswire/ -- Koning Health is excited to announce the upcoming installation of its innovative Koning…

1 year ago

mpathic Receives SBIR Award to Address Racial Bias in Healthcare AI

Care providers' cultural attunement deficiency is a historic mental health care barrier for racial and ethnic minority communities, while bias…

1 year ago

KOLON TISSUEGENE COMPLETES PATIENT DOSING IN TWO PIVOTAL US PHASE III CLINICAL TRIALS FOR TG-C

Completed patient dosing in US Phase 3 clinical trials.There will be a two-year follow-up period, followed by submission of the…

1 year ago